139 related articles for article (PubMed ID: 1378162)
21. Acute myeloid leukemias with chromosomal abnormalities involving the 21q22 region identified by their in vitro responsiveness to interleukin-5.
Touw I; Donath J; Pouwels K; van Buitenen C; Schipper P; Santini V; Hagemeijer A; Löwenberg B; Delwel R
Leukemia; 1991 Aug; 5(8):687-92. PubMed ID: 1715959
[TBL] [Abstract][Full Text] [Related]
22. The effects of IL-1 beta and IL-4 on the proliferation and endogenous secretion of growth factors by acute myeloblastic leukemic cells.
Wagteveld AJ; Esselink MT; Limburg P; Halie MR; Vellenga E
Leukemia; 1992 Oct; 6(10):1020-4. PubMed ID: 1405754
[TBL] [Abstract][Full Text] [Related]
23. Effects of interleukin-6 and granulocyte colony-stimulating factor on the proliferation of leukemic blast progenitors from acute myeloblastic leukemia patients.
Suzuki T; Morio T; Tohda S; Nagata K; Yamashita Y; Imai Y; Aoki N; Hirashima K; Nara N
Jpn J Cancer Res; 1990 Oct; 81(10):979-86. PubMed ID: 1699919
[TBL] [Abstract][Full Text] [Related]
24. Stem cell factor stimulates the in vitro growth of bone marrow cells from aplastic anemia patients.
Wodnar-Filipowicz A; Tichelli A; Zsebo KM; Speck B; Nissen C
Blood; 1992 Jun; 79(12):3196-202. PubMed ID: 1375845
[TBL] [Abstract][Full Text] [Related]
25. Regulation of the genes for interleukin-6 and granulocyte-macrophage colony stimulating factor by different inducers of differentiation in myeloid leukemic cells.
Shabo Y; Lotem J; Sachs L
Leukemia; 1989 Dec; 3(12):859-65. PubMed ID: 2685477
[TBL] [Abstract][Full Text] [Related]
26. Effect of protein kinase inhibitors on the proliferation of leukemic cells stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor or interleukin-3.
Tohda S; Nara N; Imai Y; Aoki N
Leukemia; 1991 Sep; 5(9):813-4. PubMed ID: 1719309
[TBL] [Abstract][Full Text] [Related]
27. Divergent effects of interleukin-4 (IL-4) on the granulocyte colony-stimulating factor and IL-3-supported myeloid colony formation from normal and leukemic bone marrow cells.
Vellenga E; de Wolf JT; Beentjes JA; Esselink MT; Smit JW; Halie MR
Blood; 1990 Feb; 75(3):633-7. PubMed ID: 1688720
[TBL] [Abstract][Full Text] [Related]
28. Effect of mast cell growth factor (c-kit ligand) on clonogenic leukemic precursor cells.
Goselink HM; Williams DE; Fibbe WE; Wessels HW; Beverstock GC; Willemze R; Falkenburg JH
Blood; 1992 Aug; 80(3):750-7. PubMed ID: 1638026
[TBL] [Abstract][Full Text] [Related]
29. Modulation of leukemic cell growth by tumor necrosis factor: action and expression in myeloid leukemia.
Steffen M; Budde-Steffen C; Gabrilove JL; Moore MA
Leukemia; 1992 Jul; 6(7):634-41. PubMed ID: 1378161
[TBL] [Abstract][Full Text] [Related]
30. Selective regulation by hydrocortisone of induction of in vivo differentiation of myeloid leukemic cells with granulocyte-macrophage colony-stimulating factor, interleukin 6 and interleukin 1 alpha.
Lotem J; Sachs L
Leukemia; 1992 May; 6(5):426-31. PubMed ID: 1593907
[TBL] [Abstract][Full Text] [Related]
31. Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.
Hiddemann W; Kiehl M; Zühlsdorf M; Busemann C; Schleyer E; Wörmann B; Büchner T
Semin Oncol; 1992 Apr; 19(2 Suppl 4):31-7. PubMed ID: 1553573
[TBL] [Abstract][Full Text] [Related]
32. Blasts from patients with acute myelogenous leukemia express functional receptors for stem cell factor.
Broudy VC; Smith FO; Lin N; Zsebo KM; Egrie J; Bernstein ID
Blood; 1992 Jul; 80(1):60-7. PubMed ID: 1377054
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors.
Estrov Z; Kurzrock R; Estey E; Wetzler M; Ferrajoli A; Harris D; Blake M; Gutterman JU; Talpaz M
Blood; 1992 Apr; 79(8):1938-45. PubMed ID: 1373331
[TBL] [Abstract][Full Text] [Related]
34. Dissociation of the proliferation and differentiation stimuli of granulocyte colony-stimulating factor (G-CSF).
Irvine AE; Berney JJ; Francis GE
Leukemia; 1990 Mar; 4(3):203-9. PubMed ID: 1690319
[TBL] [Abstract][Full Text] [Related]
35. In vivo control of differentiation of myeloid leukemic cells by recombinant granulocyte-macrophage colony-stimulating factor and interleukin 3.
Lotem J; Sachs L
Blood; 1988 Feb; 71(2):375-82. PubMed ID: 2447982
[TBL] [Abstract][Full Text] [Related]
36. Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor beta 1 and cancer chemotherapy compounds in myeloid leukemic cells.
Lotem J; Sachs L
Blood; 1992 Oct; 80(7):1750-7. PubMed ID: 1382703
[TBL] [Abstract][Full Text] [Related]
37. Treatment with interleukin-3 plus granulocyte-macrophage colony-stimulating factors improves the selectivity of Ara-C in vitro against acute myeloid leukemia blasts.
Bhalla K; Holladay C; Arlin Z; Grant S; Ibrado AM; Jasiok M
Blood; 1991 Nov; 78(10):2674-9. PubMed ID: 1824260
[TBL] [Abstract][Full Text] [Related]
38. Biological characteristics of CD7 positive acute myelogenous leukaemia.
Eto T; Akashi K; Harada M; Shibuya T; Takamatsu Y; Teshima T; Niho Y
Br J Haematol; 1992 Nov; 82(3):508-14. PubMed ID: 1283077
[TBL] [Abstract][Full Text] [Related]
39. Modulation of myeloid proliferation and differentiation by monoclonal antibodies directed against a protein that interacts with the interleukin-3 receptor.
Tweardy DJ; Morel PA; Mott PL; Glazer EW; Zeh HJ; Sakurai M
Blood; 1992 Jul; 80(2):359-66. PubMed ID: 1378315
[TBL] [Abstract][Full Text] [Related]
40. Early effects of G- and GM-CSF upon HL-60 proliferation and differentiation.
Elias L; Van Epps DE
Leukemia; 1988 Nov; 2(11):763-5. PubMed ID: 2460707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
